- Bevorzugter Name
- [2-Fluoro-4-(methanesulfonyl)phenyl][6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yl]amine
- IUPAC
- N-[2-Fluoro-4-(methanesulfonyl)phenyl]-5-nitro-6-{4-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl}pyrimidin-4-amine
- Englischer Name
- AR 231453
- Summenformel
- C21H24FN7O5S
- Molmasse
- 505.52
Namen und Synonyme
CS-2809AR 231453AR231453AR-231453AR 231453, 10 mM in DMSOAR 231453, GPR119 agonistN-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-niN-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-amineN-(2-fluoro-4-methylsulfonylphenyl)-5-nitro-6-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]pyrimidin-4-amineinhibit,GPR119,AR-231453,G Protein-Coupled Receptor 119,diabetes,AR231453,AR 231453,insulin,Inhibitor,HIT-T15,glucose,GPCR
Datenbank-Bezeichner
- PubChem CID
- 24939268
- DTXSID
DTXSID80223614- ChEMBL
CHEMBL461384- UNII
- 07Z1P4981I
- Nikkaji
- J2.928.735J